Nadine Stokar

ESTP Congress
,

Nadine is a Toxicologic Pathologist at Roche and leads the Investigative Pathology scientific area in the Preclinical Pathology team. She is involved in discovery and regulatory drug development projects. Her expertise includes characterization of genetically engineered animal models and in vitro models for human diseases as alternative models in preclinical drug development.

In the ESTP Pathology 2.0 initiative, she co-leads the ESTP&STP working group “Complex in vitro models & Pathology” with Lindsay Tomlinson (Pfizer).